The information in this section is intended for visitors outside the United States.
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C
Gilead Sciences to Present at the Barclays Global Healthcare Conference on Wednesday, March 11
Gilead Sciences to Present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3
2014 Annual Review